Key facts
- It has raised $39.6M; the latest was Debt Refinancing ($20.0M) in Aug 2025.
- Notable investors include Plug and Play Tech Center, Catalio Capital Management, CVS Health Ventures, Mentors Fund, Nanban Ventures — 7 tracked in total.
- Status: Privately Held (backing).
Leadership
- Bharath SudharsanExecutive & Head
- Chris BergstromPresident
- Jennifer MainChief Financial Officer & Chief Operating Officer
- Matti PrasadChief Technology Officer
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Amalgam
- ·The full record, as it builds
Funding rounds
No funding rounds for Amalgam are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Amalgam
Operator of a digital healthcare platform intended to improve clinical and behavioral outcomes for chronic disease management. The company's platform provides a variety of features, such as data insights, clinical decision support tools, and patient engagement tools, enabling healthcare providers to improve patient care and reduce costs.
- Sector
- Healthcare
- HQ
- Wilmington, DE, United States
- Founded
- 2016
- Employees
- 61
- Website
- amalgamrx.com/
- Ownership
- Privately Held (backing)
Amalgam doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amalgam shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amalgam in its N-PORT filings yet. We sweep new filings monthly.